m+Medelevator.RU
← Поиск публикаций
Scientific reports · 2026

Effect of intratumoral alpha radiation on tumor growth delay and tumor microenvironment in an orthotopic colorectal liver metastasis murine model.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zlotnik Oran, Tsatoumas Anastasia, Kapelanski-Lamoureux Audrey, Gantz Amatzia, Rada Miran, Petrillo Stephanie K, Kalil Jennifer, Packer Shmuel, Deutsch Lisa, Segal Ronen, Gao Zu-Hua, Lazaris Anthoula, Domankevich Vered, Metrakos Peter

Аннотация

Colorectal cancer frequently spreads to the liver, and current treatments often damage healthy liver tissue, while targeting tumors. Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) disperses alpha-emitting atoms from an intra-tumoral implanted source to a range of a few millimeters in the tumor. Alpha radiation is highly efficient in killing cancer cells, compared to other radiation types, and its short range in the tissue, potentially enables sparing healthy tissue adjacent to the tumor. Alpha DaRT's efficacy was previously demonstrated in subcutaneous tumors from various histotypes. Yet its effectiveness in treating tumors located in an internal organ, such as the liver, remains to be tested in animal studies. Here, we used a single liver metastasis orthotopic model by implanting MC38 colorectal metastatic tissue in mice livers. The metastasis was then treated either with a single radioactive or inert Alpha-DaRT source. Alpha-DaRT effectively delayed tumor growth without damaging the surrounding liver parenchymal tissue. F4/80 + immunosuppressive macrophages in the tumor-normal tissue interface were reduced following treatment. The findings suggest that this type of radiation therapy could be a promising option for treating patients with liver tumors.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты